Hadrien Lanvin appointed Deputy Managing Director of the Aton Group

The Aton Group, a player in the life sciences and medical technologies sector, has announced the appointment of Hadrien Lanvin as Deputy Chief Executive Officer. A graduate of HEC Paris, Lanvin founded Evora Biosciences. A member of Aton's board of directors since 2023, he is very familiar with the Group's assets.

In his new role, he will facilitate the valuation of Aton's assets by strengthening their market positioning and will collaborate with subsidiary leaders to support their growth and visibility within the financial community. According to Léone Atayi, President of Aton, his biotech knowledge and experience will strengthen the management team at a crucial time.